PLAU and glioblastoma: When the expression alterations in initial GBM diagnosis and recurrence after treatment were evaluated, VEGF-VEGFR2/VEGFR1 axis, HIF1α, urokinase plasminogen activator (uPA), CXCL12, and CXCR4, changes were shown between RNA and protein expression.